Annamaria Rapisarda

4.7k total citations · 1 hit paper
38 papers, 3.8k citations indexed

About

Annamaria Rapisarda is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Annamaria Rapisarda has authored 38 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cancer Research, 17 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Annamaria Rapisarda's work include Cancer, Hypoxia, and Metabolism (29 papers), Neuroblastoma Research and Treatments (7 papers) and Cancer Research and Treatments (6 papers). Annamaria Rapisarda is often cited by papers focused on Cancer, Hypoxia, and Metabolism (29 papers), Neuroblastoma Research and Treatments (7 papers) and Cancer Research and Treatments (6 papers). Annamaria Rapisarda collaborates with scholars based in United States, Italy and Spain. Annamaria Rapisarda's co-authors include Giovanni Melillo, Badarch Uranchimeg, Robert H. Shoemaker, Subhra K. Biswas, Edward A. Sausville, Dominic A. Scudiero, Antonio Sica, Sergio Bernasconi, Manuela Nebuloni and Alberto Mantovani and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Annamaria Rapisarda

36 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of the Chemokine Receptor CXCR4 by Hypoxia

2003 671 citations Badarch Uranchimeg, Subhra K. Biswas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annamaria Rapisarda United States	26	2.0k	1.9k	1.1k	881	353	38	3.8k
Balaji Krishnamachary United States	31	2.4k 1.2×	2.1k 1.1×	927 0.9×	379 0.4×	547 1.5×	87	4.4k
Atul Bedi United States	23	3.2k 1.6×	2.0k 1.0×	1.6k 1.5×	639 0.7×	418 1.2×	29	4.8k
Zhimin He China	36	3.0k 1.5×	1.4k 0.7×	1.2k 1.1×	422 0.5×	284 0.8×	108	4.2k
Hannes Hentze Singapore	24	2.4k 1.2×	1.4k 0.7×	954 0.9×	372 0.4×	544 1.5×	37	4.1k
Keiji Shimada Japan	42	2.5k 1.3×	1.0k 0.5×	1.4k 1.3×	788 0.9×	694 2.0×	161	4.9k
Arántzazu Alfranca Spain	33	1.5k 0.8×	814 0.4×	772 0.7×	737 0.8×	372 1.1×	70	3.3k
Ann Zeuner Italy	35	2.4k 1.2×	867 0.4×	1.4k 1.3×	879 1.0×	275 0.8×	72	4.3k
Oliver Stoeltzing United States	43	3.0k 1.5×	1.4k 0.7×	1.6k 1.5×	383 0.4×	538 1.5×	73	4.6k
Matvey Lukashev United States	16	1.5k 0.8×	809 0.4×	596 0.6×	626 0.7×	441 1.2×	22	3.7k
Yasuhiro Hida Japan	42	3.0k 1.5×	1.8k 0.9×	1.7k 1.6×	910 1.0×	815 2.3×	162	5.5k

Countries citing papers authored by Annamaria Rapisarda

Since Specialization

Citations

This map shows the geographic impact of Annamaria Rapisarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annamaria Rapisarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annamaria Rapisarda more than expected).

Fields of papers citing papers by Annamaria Rapisarda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annamaria Rapisarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annamaria Rapisarda. The network helps show where Annamaria Rapisarda may publish in the future.

Co-authorship network of co-authors of Annamaria Rapisarda

This figure shows the co-authorship network connecting the top 25 collaborators of Annamaria Rapisarda. A scholar is included among the top collaborators of Annamaria Rapisarda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annamaria Rapisarda. Annamaria Rapisarda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shalova, Irina N., Manesh Chittezhath, Annelies S. Zinkernagel, et al.. (2015). Human Monocytes Undergo Functional Re-programming during Sepsis Mediated by Hypoxia-Inducible Factor-1α. Immunity. 42(3). 484–498. 315 indexed citations

Morris, Joel, Mark W. Kunkel, Eric C. Polley, et al.. (2014). Abstract 5475: Interrogation of NCI-60 patterns of growth inhibition in conjunction with investigational oncology agents kinase profiling for the elucidation of mechanistic targets. Cancer Research. 74(19_Supplement). 5475–5475.

Jeong, Woondong, Sook Ryun Park, Annamaria Rapisarda, et al.. (2013). Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors. Investigational New Drugs. 32(2). 340–346. 23 indexed citations

Jeong, Woondong, Sook Ryun Park, Annamaria Rapisarda, et al.. (2013). Abstract 2416: Weekly EZN-2208 (pegylated SN-38) in combination with bevacizumab in patients with refractory solid tumors.. Cancer Research. 73(8_Supplement). 2416–2416. 1 indexed citations

Fer, Nicole, et al.. (2013). Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells. Journal of Clinical Investigation. 123(4). 1615–1629. 63 indexed citations

Rapisarda, Annamaria & Giovanni Melillo. (2012). Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nature Reviews Clinical Oncology. 9(7). 378–390. 136 indexed citations

Kummar, Shivaani, Mark Raffeld, Lamin Juwara, et al.. (2011). Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors. Clinical Cancer Research. 17(15). 5123–5131. 100 indexed citations

Rapisarda, Annamaria, Robert H. Shoemaker, & Giovanni Melillo. (2009). Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads. Cell Cycle. 8(24). 4040–4043. 20 indexed citations

Rapisarda, Annamaria & Giovanni Melillo. (2009). Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies. Drug Resistance Updates. 12(3). 74–80. 109 indexed citations

10.

Rapisarda, Annamaria, Melinda G. Hollingshead, Badarch Uranchimeg, et al.. (2009). Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Molecular Cancer Therapeutics. 8(7). 1867–1877. 136 indexed citations

11.

Rapisarda, Annamaria, et al.. (2009). Development of HIF‐1 inhibitors for cancer therapy. Journal of Cellular and Molecular Medicine. 13(9a). 2780–2786. 211 indexed citations

12.

Rapisarda, Annamaria, et al.. (2008). Synergystic induction of HIF-1α transcriptional activity by hypoxia and lipopolysaccharide in macrophages. Cell Cycle. 7(2). 232–241. 51 indexed citations

13.

Cardellina, John H., Andrew G. Stephen, Annamaria Rapisarda, et al.. (2007). Cell Type–Specific, Topoisomerase II–Dependent Inhibition of Hypoxia-Inducible Factor-1α Protein Accumulation by NSC 644221. Clinical Cancer Research. 13(3). 1010–1018. 45 indexed citations

14.

Rapisarda, Annamaria & Giovanni Melillo. (2007). UVC inhibits HIF-1α protein translation by a DNA damage- and topoisomerase I-independent pathway. Oncogene. 26(48). 6875–6884. 16 indexed citations

15.

Melillo, Giovanni, Martin Gutierrez, Beata Holkova, et al.. (2007). A pilot trial of topotecan administered orally in patients with advanced solid tumors expressing hypoxia inducible factor (HIF)- 1α. Journal of Clinical Oncology. 25(18_suppl). 14103–14103. 1 indexed citations

16.

Bosco, Maria Carla, Maura Puppo, Sandra Pastorino, et al.. (2004). Hypoxia Selectively Inhibits Monocyte Chemoattractant Protein-1 Production by Macrophages. The Journal of Immunology. 172(3). 1681–1690. 81 indexed citations

17.

Rapisarda, Annamaria, Melinda G. Hollingshead, Till Braunschweig, et al.. (2004). Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts. Cancer Research. 64(19). 6845–6848. 162 indexed citations

18.

Bosco, Maria Carla, et al.. (2003). Macrophage Activating Properties of The Tryptophan Catabolite Picolinic Acid. Advances in experimental medicine and biology. 527. 55–65. 36 indexed citations

19.

Rapisarda, Annamaria, Badarch Uranchimeg, Dominic A. Scudiero, et al.. (2002). Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.. PubMed. 62(15). 4316–24. 397 indexed citations

20.

Bosco, Maria Carla, et al.. (2000). The Tryptophan Catabolite Picolinic Acid Selectively Induces the Chemokines Macrophage Inflammatory Protein-1α and -1β in Macrophages. The Journal of Immunology. 164(6). 3283–3291. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact